Welcome to our dedicated page for iTonic Holdings SEC filings (Ticker: ITOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on iTonic Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into iTonic Holdings's regulatory disclosures and financial reporting.
iTonic Holdings Ltd filed an amended Form 20-F mainly to correct the date on Marcum Asia CPAs LLP’s audit report; no other disclosures were changed, although new CEO and CFO certifications were included.
For 2025, iTonic reported revenue of $523,031 and a net loss of $5,098,384, driven by sharp increases in general and administrative and research and development expenses. The auditor and management highlight substantial doubt about the company’s ability to continue as a going concern, noting operating losses, negative operating cash flow of $3,231,427 and the need for additional equity or debt financing to fund operations.
Total assets were $9,096,296 at year-end 2025, including newly recognized goodwill of $1,955,683 and customer-relationship intangibles of $2,414,357 from acquisitions. Cash and cash equivalents fell to $1,490,129 from $6,159,823 as the company invested in short-term investments, acquisitions and operations. Class A ordinary shares outstanding increased to 9,382,000, partly reflecting a 2,800,000-share-based payment in 2025 on top of the 2024 IPO of 2,250,000 Class A shares.
iTonic Holdings Ltd, a Cayman Islands company with operating subsidiary Beijing Feitian, files its annual Form 20-F covering the year ended December 31, 2025. The business focuses on brachytherapy treatment planning software and related medical auxiliary supplies for cancer care in China.
All revenue and operations are in the PRC, so results depend heavily on China’s economic conditions, healthcare policies and medical device regulations. The report emphasizes reliance on multiple PRC licenses and production/operation permits, foreign-exchange and dividend remittance controls, evolving cybersecurity and data rules, and potential PRC tax-residency and withholding tax exposure. It also highlights rising labor and social-benefit costs, stricter employment compliance, and uncertainties around foreign investment, M&A and overseas listings rules that could affect future financing and expansion.
iTonic Holdings Ltd has agreed to a March 2026 private placement of 100,000,000 Class A ordinary shares at US$0.20 per share, for aggregate gross proceeds of about US$20,000,000 to the company. The transaction is expected to close in April 2026, subject to the conditions in the subscription agreement.
The new shares will be subject to a six-month lock-up period from issuance, limiting immediate resale. This report is also incorporated by reference into iTonic’s existing Form S-8 and effective Form F-3 registration statements.
iTonic Holdings Ltd director Zhang Pengfei filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing does not report any stock purchases, sales, option exercises, or other transactions; it simply establishes Zhang’s status as a reporting director at iTonic Holdings.
iTonic Holdings Ltd executive Li Zhixin, the company’s CFO, has filed an initial Form 3 as an officer of the company. The provided data does not show any insider transactions or derivative positions, indicating this filing functions mainly as a baseline ownership disclosure.
iTonic Holdings Ltd has filed a shelf registration to offer up to US$200,000,000 of Class A ordinary shares, preferred shares, debt securities, warrants, rights, depositary shares and units from time to time. The company’s Class A shares trade on Nasdaq under “ITOC,” with a public float of about US$4.0 million based on 9,382,000 Class A shares held by non‑affiliates as of February 3, 2026.
iTonic is a Cayman holding company whose healthcare and home‑care technology operations are conducted through subsidiaries in China and the U.S. Recent results show modest revenues and increasing net losses. The filing highlights significant legal and regulatory risks tied to operating in China, potential impacts from evolving PRC oversight of overseas offerings, and uncertainties related to PCAOB inspection requirements under the HFCA and Accelerating HFCA Acts, any of which could adversely affect the business and the value of its securities.
iTonic Holdings Ltd reported a board change and disclosed the standard terms of its director agreement. On January 22, 2026, independent director Yun Fai Wong resigned from the board for personal reasons, with the company stating there was no disagreement regarding its operations, policies or practices. The board simultaneously appointed Bin Wu as a new independent director and as a member of the Audit, Corporate Governance and Nominating, and Compensation Committees, and named him chair of the Corporate Governance and Nominating Committee.
iTonic notes that Bin Wu graduated from Wuhan University and holds an MBA from Duke University, and believes he meets Nasdaq and SEC independence standards. The filing includes a form of director agreement and indemnification agreement, outlining a fixed board term, quarterly cash fees, annual option grants under a share incentive plan, confidentiality and non-solicitation covenants, D&O insurance coverage, and Cayman Islands governing law.